Concepedia

Kim De Veirman

KD

Statistics

Publications

39

Citations

2.2K

H-Index

27

Active since

2013

Affiliations

Vrije Universiteit Brussel(Current)

Universitair Ziekenhuis Brussel

Ghent University Hospital

Centre National de la Recherche Scientifique

Centre Hospitalier Universitaire de Montpellier

Kim De Veirman is an author at Vrije Universiteit Brussel specializing in medicine, multiple myeloma, and oncology.

ORCID

Publications per year

2013–2024

39

Publications

39

Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression

Jinheng Wang, Kim De Veirman, Sylvia Faict et al. · The Journal of Pathology · 2016 · 231 citations · Full text

, , +16

Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts

Sylvia Faict, Joséphine Muller, Kim De Veirman et al. · Blood Cancer Journal · 2018 · 153 citations · Full text

, , +17

The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells

Jinheng Wang, Kim De Veirman, Nathan De Beule et al. · Oncotarget · 2015 · 147 citations · Full text

, , +17

A niche-dependent myeloid transcriptome signature defines dormant myeloma cells

Weng Hua Khoo, Guy Ledergor, Assaf Weiner et al. · Blood · 2019 · 137 citations · Full text

, , +14

Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity

Kim De Veirman, Jinheng Wang, Song Xu et al. · Cancer Letters · 2016 · 133 citations

, , +16

1–5 of 39